Search

everythinglearnresearchcommunity

for

Search:↓

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

Injury boosts normal skin cell growth, reducing cancer cell advantage.

Hair follicle regeneration may slow tumor growth.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

Suppressing very long chain fatty acids is linked to skin cancer.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Activated ras can protect kidney cells from a certain substance that causes cell death.

CRISPR/Cas9 editing in spinach affects root hair growth by altering specific genes.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Mutations in Plcd1 and Plcd3 together cause severe hair loss in mice.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

AP-1 controls tumor cell type by affecting key signaling pathways.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Some drugs may help treat both COVID-19 and radiation injury.

Activating Kras in mouse skin causes excess skin and hair loss.

Disrupting Smad4 in mouse skin causes early hair follicle stem cell activity that leads to their eventual depletion.